Category: Boston Scientific
Boston Scientific launches a clinical trial for its Acuity X4 pacemaker and Reliance 4-Front defibrillator leads, ahead of its bid for U.S. FDA approval of the devices.
keys: boston scientific, bsx, acuity x4, reliance 4-front
Here's a look at some of the top legal news stories for medical device companies this week.
Boston Scientific gets the FDA's OK for a new generation of defibrillators and heart failure devices, including some of the world's smallest and thinnest ICDs.
Boston Scientific (NYSE:BSX) announced this week that it won FDA approval for its newest suite of cardiac devices, including next-generation defibrillators and heart failure devices.
A federal appeals court vacates a lower court's decision to keep Boston Scientific's Guidezilla catheter off the U.S. market in the patent infringement lawsuit brought by Vascular Solutions.
Plaintiffs in product liability lawsuits against several makes of pelvic mesh products, including Boston Scientific, Johnson & Johnson and Secant Medical, want a federal judge to send the cases back to a Pennsylvania state court.
Medtech titan Boston Scientific enrolls the first patient in a clinical registry evaluating the Vercise deep brain stimulation system for Parkinson's disease.
Boston Scientific (NYSE:BSX) kicked off a new registry evaluating deep brain stimulation in treatment of Parkinson's disease.
Medtech titan Boston Scientific plans to sell a slew of its products in Israel through a partnership with distributor Amos Gazit Ltd and marketing group Medison.
Massachusetts medical device maker Boston Scientific (NYSE:BSX) has a new partner in Israel, agreeing to supply a slate of its products through local distributor Amos Gazit Ltd